20/20 Biolabs Inc. (AIDX)
$0.52-5.45%Close
BUY
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $3M
- Avg volume
- 587.0K
- Beta
- 1.54
- P/E (TTM)
- -0.62
- Short % float
- 3.58%
- Days to cover
- 1.3
- SI change
- -38.4%
- 1W
- -5.45%
- 1M
- +6.12%
- 3M
- -46.94%
- YTD
- -97.82%
- vs SPY 1W
- -4.26%
- vs SPY 1M
- +2.80%
- vs SPY 3M
- -49.33%
- vs SPY YTD
- -109.57%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- CSCIBUYCOSCIENS Biopharma Inc.RECOVERYQ -7$2.72+0.00%
- MBIOSELLMustang Bio, Inc.CRISISQ -18$0.55-5.17%
- INMSELLInMed Pharmaceuticals Inc.CRISISQ -11$1.43-2.05%
- PTNBUYPalatin Technologies, Inc.RECOVERYQ -4$10.16+4.85%
- AQSTBUYAquestive Therapeutics, Inc.RECOVERYQ -4$4.80+3.00%
- ITOCBUYiTonic Holdings Ltd.CRISISQ -21$0.27-6.90%
- ANVSBUYAnnovis Bio, Inc.RECOVERYQ 3$1.75-3.85%
- GYREBUYGyre Therapeutics, Inc.RECOVERYQ -2$6.44-6.80%
- IBRXBUYImmunityBio, Inc.RECOVERYQ 7$7.58-2.70%
- MNDRSELLMobile-health Network Solutions Class A Ordinary SharesCRISISQ -29$1.65-1.20%
- NRXSSELLNeurAxis, Inc.BEARQ 15$6.07-1.30%
- QNRXSELLQuoin Pharmaceuticals, Ltd.RECOVERYQ -19$5.42-2.69%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 7
- VALUE
- 5
- GROWTH
- 24
- GARP
- 9
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC105.7%
REV YoY-
ROE176.2%
EPS YoY-
ROA-95.0%
GROSS32
OP-216
NET-285
[VALUATION]
P/E TTM-0.62
P/E FWD-
SECTOR PE22.62
INDUSTRY PE30.32
P/B1.78
P/FCF-
EV/EBITDA-0.59
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E18.12
ALTMAN Z-
CURR RATIO1.99
ND/EBITDA-
BETA1.54
